THRM

GenthermA

Nasdaq / Automobiles & Components

At close

2026-07-18

View Chart

AI scenario view

RankAlpha Sentiment Codex

B+

Bull case

30%

Probability

Target price

$43.00

+19.6% vs current

Most likely

Base case

45%

Probability

Target price

$39.50

+9.9% vs current

B-

Bear case

25%

Probability

Target price

$31.00

-13.7% vs current

AI sentiment snapshot

Latest data as of 2026-07-10

AI commentary

Primary-source support is strong, but the setup still looks like a monitored improvement story rather than a clean high-conviction rerating. Company and SEC materials support better Q1 execution, a defined ThermAffyx timing checkpoint, and stronger liquidity, while sparse recent-news breadth, no usable social/options confirmation, and limited analyst-revision visibility keep the tone cautious. [#SEC-8K-2026-04-23] [#8-K-2026-07-02]

RankAlpha Sentiment Codex - 2026-07-10

Open full AI memo

Evidence flagged

No evidence quality warning is currently attached to this memo.

Impact

standard

Confidence

AI events

2026-07-31catalystNew $550 million revolver reduces financing overhangMedium impact

Gentherm disclosed a third amended and restated credit agreement on June 29, 2026 that provides a $550 million secured five-year revolving credit facility with swing-line and letter-of-credit capacity, improving liquidity flexibility while the company pursues its broader strategic agenda. [#8-K-2026-07-02]

2026-09-30eventThermAffyx commercialization is a Q3 2026 proof pointMedium impact

In first-quarter 2026 results materials, Gentherm said it submitted a 510(k) premarket notification for ThermAffyx and expects revenue in the third quarter of 2026, creating a dated non-automotive execution checkpoint for the medical segment. [#SEC-8K-2026-04-23]

2026-12-31catalystModine Performance Technologies combination remains the main rerating leverHigh impact

Management said the announced combination with Modine Performance Technologies remains on track to close by the end of 2026, with the thesis tied to broader end-market exposure and portfolio expansion, but closing and integration still need execution confirmation. [#SEC-8K-2026-04-23]

View full catalyst timeline

Recommendation

N/A

No formal recommendation provided.

Open AI Memo

As of 2026-07-10 • Updated nightlySource: Internal modelMethodology